Published in Curr Probl Cancer on January 19, 2010
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys (2016) 0.80
HIV- positive anal cancer: an update for the clinician. J Gastrointest Oncol (2010) 0.79
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA (2008) 4.61
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys (2007) 3.87
Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol (2008) 3.44
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys (2008) 2.45
Bibliometric analysis of radiation oncology departmental scholarly publication productivity at domestic residency training institutions. J Am Coll Radiol (2009) 2.33
Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol (2011) 2.10
Current status of diversity by race, Hispanic ethnicity, and sex in diagnostic radiology. Radiology (2013) 2.02
Melatonin: from basic research to cancer treatment clinics. J Clin Oncol (2002) 1.99
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol (2012) 1.84
Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene (2003) 1.78
Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol (2008) 1.78
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys (2012) 1.70
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy. J Clin Oncol (2009) 1.65
Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer (2007) 1.63
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J Clin Oncol (2004) 1.61
Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. Int J Radiat Oncol Biol Phys (2007) 1.61
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys (2006) 1.60
Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys (2003) 1.57
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol (2011) 1.54
Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys (2004) 1.53
Radiation therapy in the postoperative management of esophageal cancer. J Gastrointest Oncol (2010) 1.48
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07. J Clin Oncol (2010) 1.47
Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer (2007) 1.44
Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012). Dis Colon Rectum (2016) 1.40
Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol (2007) 1.35
Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys (2010) 1.30
"If God wanted me yesterday, I wouldn't be here today": religious and spiritual themes in patients' experiences of advanced cancer. J Palliat Med (2010) 1.30
Locally advanced duodenal gangliocytic paraganglioma treated with adjuvant radiation therapy: case report and review of the literature. World J Surg Oncol (2005) 1.27
Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys (2004) 1.25
Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators. Clin Cancer Res (2010) 1.22
Relative lack of conditional survival improvement in young adults with cancer. Semin Oncol (2009) 1.21
BRCA1- and BRCA2-deficient cells are sensitive to etoposide-induced DNA double-strand breaks via topoisomerase II. Cancer Res (2007) 1.21
Conditional Survival in Rectal Cancer: A SEER Database Analysis. Gastrointest Cancer Res (2007) 1.21
Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist (2004) 1.15
The role of spirituality and religious coping in the quality of life of patients with advanced cancer receiving palliative radiation therapy. J Support Oncol (2011) 1.15
A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys (2005) 1.14
Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis. Cancer (2009) 1.14
Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survival. Am J Clin Oncol (2006) 1.13
The relationship of spiritual concerns to the quality of life of advanced cancer patients: preliminary findings. J Palliat Med (2011) 1.10
Superior sulcus tumors: a mini-review. Oncologist (2004) 1.10
Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.10
Flawed assumptions used to defend screening mammography. Cancer (2014) 1.09
Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer (2010) 1.09
Therapeutic exploitation of tumor cell defects in homologous recombination. Anticancer Agents Med Chem (2008) 1.08
Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys (2006) 1.06
Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist (2004) 1.05
PET/CT of cancer patients: part 1, pancreatic neoplasms. AJR Am J Roentgenol (2012) 1.02
Disparities in cancer care: a worldwide perspective and roadmap for change. J Clin Oncol (2006) 1.02
Multimodality approaches for pancreatic cancer. CA Cancer J Clin (2005) 1.01
Estimation of citation-based scholarly activity among radiation oncology faculty at domestic residency-training institutions: 1996-2007. Int J Radiat Oncol Biol Phys (2008) 1.01
Radiotherapy and breast reconstruction: complications and cosmesis with TRAM versus tissue expander/implant. Int J Radiat Oncol Biol Phys (2002) 1.00
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer (2008) 0.99
Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer (2011) 0.99
Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys (2004) 0.99
Adhesion molecules in radiotherapy. Radiat Res (2006) 0.97
Homologous recombination is the principal pathway for the repair of DNA damage induced by tirapazamine in mammalian cells. Cancer Res (2008) 0.96
Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin (2008) 0.96
Clinicians communicating with patients experiencing cancer pain. Cancer Invest (2003) 0.96
Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature. Am J Clin Oncol (2002) 0.96
RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results. Int J Radiat Oncol Biol Phys (2011) 0.95
Sixty years of CA: a cancer journal for clinicians. CA Cancer J Clin (2010) 0.95
Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer (2011) 0.94
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.94
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). J Thorac Oncol (2012) 0.93
An interactive tool for individualized estimation of conditional survival in rectal cancer. Ann Surg Oncol (2011) 0.93
Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med (2014) 0.93
External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Gastroenterology (2004) 0.92
Lung dose-volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy. J Clin Oncol (2009) 0.92
Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys (2003) 0.92
Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg (2006) 0.91
Stereotactic body radiation therapy: an ablative treatment option for primary and secondary liver tumors. Ann Surg Oncol (2004) 0.91
Gastric cancer: standards for the 21st century. Crit Rev Oncol Hematol (2006) 0.91
Esophageal carcinoma. N Engl J Med (2015) 0.91
Squamous cell carcinoma of the anal canal. Surg Oncol (2005) 0.91
Anal cancer: current standards in care and recent changes in practice. CA Cancer J Clin (2015) 0.90
Detection of impaired homologous recombination repair in NSCLC cells and tissues. J Thorac Oncol (2013) 0.89
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial. Int J Radiat Oncol Biol Phys (2013) 0.89
The role of positron emission tomography in esophageal cancer. Gastrointest Cancer Res (2008) 0.89
Biomarkers and mechanisms of FANCD2 function. J Biomed Biotechnol (2008) 0.89
External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study. Int J Radiat Oncol Biol Phys (2012) 0.89
Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer. AMIA Annu Symp Proc (2010) 0.88
Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer. J Thorac Cardiovasc Surg (2013) 0.88
Case report and summary of literature: giant perineal keloids treated with post-excisional radiotherapy. BMC Dermatol (2006) 0.88
Success breeds success: authorship distribution in the Red Journal, 1975-2011. Int J Radiat Oncol Biol Phys (2012) 0.88
Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis. Cancer (2013) 0.88
ACR Appropriateness Criteria® Resectable Stomach Cancer. Oncology (Williston Park) (2015) 0.88
Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment. Int J Radiat Oncol Biol Phys (2007) 0.87
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma. J Clin Oncol (2011) 0.87
Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315. J Natl Cancer Inst (2010) 0.87
Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies. J Gastrointest Oncol (2010) 0.87
Survey of bereavement practices of cancer care and palliative care physicians in the Pacific Northwest United States. J Oncol Pract (2012) 0.87
Radiation therapy in the management of thymic tumors. Semin Thorac Cardiovasc Surg (2005) 0.87
Rectal cancer at the crossroads: the dilemma of clinically staged T3, N0, M0 disease. J Clin Oncol (2008) 0.87
ACR appropriateness criteria® resectable rectal cancer. Radiat Oncol (2012) 0.87
Irreversible EGFR inhibitor EKB-569 targets low-LET γ-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma. PLoS One (2011) 0.86
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008. Clin Cancer Res (2009) 0.86